Literature DB >> 20429666

Chemotherapy regimens and treatment protocols for laryngeal cancer.

Missak Haigentz1, Carl E Silver, Dana M Hartl, Robert P Takes, Juan P Rodrigo, K Thomas Robbins, Alessandra Rinaldo, Alfio Ferlito.   

Abstract

IMPORTANCE OF THE FIELD: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology. Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer. AREAS COVERED IN THIS REVIEW: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer. WHAT THE READER WILL GAIN: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival. TAKE HOME MESSAGE: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx. Future challenges include identification of novel therapies and optimizing therapy protocols for individualized patient care.

Entities:  

Mesh:

Year:  2010        PMID: 20429666     DOI: 10.1517/14656561003749256

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer.

Authors:  M Hata; T Taguchi; I Koike; G Nishimura; M Takahashi; M Komatsu; D Sano; K Odagiri; Y Minagawa; T Inoue
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

Review 2.  Head and neck cancer management and cancer stem cells implication.

Authors:  Osama A Elkashty; Ramy Ashry; Simon D Tran
Journal:  Saudi Dent J       Date:  2019-06-10

3.  miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β.

Authors:  Zhong-Xin Zhou; Zu-Ping Zhang; Ze-Zhang Tao; Ting-Zhao Tan
Journal:  Oncol Res       Date:  2018-03-21       Impact factor: 5.574

4.  C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.

Authors:  Guodong Li; Xiaoling Hu; Lu Sun; Xin Li; Jianfeng Li; Tongli Li; Xiaohui Zhang
Journal:  Cell Mol Biol Lett       Date:  2018-02-20       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.